In this respect, activation of CSF-1R by its ligand is likely to occur in tumor cells in which CSF-1R and CSF-1 are co-expressed (i.e. autocrine activation), or when CSF-1R is stimulated by CSF-1 released by cancer associated fibroblasts (i.e. paracrine activation). The gene discussed is CSF1; the disease is neoplasm.